Genetic testing for inherited cardiovascular conditions has the potential to identify disease etiology, inform patient management decisions, clarify a diagnosis, and identify at-risk individuals. Access to this type of testing is increasingly available; multiple genetic tests have been developed to detect genetic variants associated with inherited cardiovascular diseases.

During this 60-minute webinar, a senior analyst and a genetic counselor from the ECRIgene team will discuss genetic testing’s role in the cardiovascular disease space and summarize available evidence assessing the clinical utility of genetic testing for various cardiac conditions. They will also discuss how results may influence decision-making in symptomatic and asymptomatic individuals, evidence gaps and limitations, and counseling considerations.

Learning Objectives

1. Understand the role of genetic testing in various heritable cardiovascular conditions such as Cardiomyopathies, Pulmonary Hypertension, Lipidemias and Aortopathies.
2. Understand the state of the evidence and evidence gaps associated with each condition.
3. Discuss how genetic testing evidence contributes to clinical decision making in symptomatic and asymptomatic individuals.
4. Summarize reimbursement trends for cardiovascular genetic testing.

Savvas Pavlides

Senior Quality Control Officer

Matthew Share

Research Analyst/Genetic Counselor